Dimension Therapeutics
Gene therapy company focused on developing novel treatments for rare diseases. Our team comprises biotech industry veterans and thought leaders in gene therapy and rare diseases.
HQ location
Cambridge, United States
Website
Launch date
Enterprise value
$260—390m
loading funding rounds…
F-Prime(exited)
OrbiMed(exited)
Jennison Associates(exited)
New Leaf Venture Partners(exited)
PFM Health Sciences(exited)
Rock Spring Ventures(exited)
RA Capital Management(exited)
Ultragenyx Pharmaceutical(exited)
Eight Roads Ventures(exited)
| EUR | 2015 | 2016 |
|---|---|---|
| Revenues | 0000 | 0000 |
| EBITDA | 0000 | 0000 |
| Profit | 0000 | 0000 |
| EV | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.